These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 31256650)

  • 1. 2019 Mark Coventry Award: A multicentre randomized clinical trial of tranexamic acid in revision total knee arthroplasty: does the dosing regimen matter?
    Fillingham YA; Darrith B; Calkins TE; Abdel MP; Malkani AL; Schwarzkopf R; Padgett DE; Culvern C; Sershon RA; Bini S; Della Valle CJ;
    Bone Joint J; 2019 Jul; 101-B(7_Supple_C):10-16. PubMed ID: 31256650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty: A Multicenter Randomized Clinical Trial.
    Sershon RA; Fillingham YA; Abdel MP; Malkani AL; Schwarzkopf R; Padgett DE; Vail TP; Nam D; Nahhas C; Culvern C; Della Valle CJ;
    J Bone Joint Surg Am; 2020 Nov; 102(21):1883-1890. PubMed ID: 33148955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-conserving efficacy of multiple doses of oral tranexamic acid associated with an enhanced-recovery programme in primary total knee arthroplasty: a randomized controlled trial.
    Wang D; Wang HY; Luo ZY; Meng WK; Pei FX; Li Q; Zhou ZK; Zeng WN
    Bone Joint J; 2018 Aug; 100-B(8):1025-1032. PubMed ID: 30062946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The James A. Rand Young Investigator's Award: A Randomized Controlled Trial of Oral and Intravenous Tranexamic Acid in Total Knee Arthroplasty: The Same Efficacy at Lower Cost?
    Fillingham YA; Kayupov E; Plummer DR; Moric M; Gerlinger TL; Della Valle CJ
    J Arthroplasty; 2016 Sep; 31(9 Suppl):26-30. PubMed ID: 27113948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
    Shin YS; Yoon JR; Lee HN; Park SH; Lee DH
    Knee Surg Sports Traumatol Arthrosc; 2017 Nov; 25(11):3585-3595. PubMed ID: 27417102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
    Tammachote N; Raphiphan R; Kanitnate S
    Eur J Orthop Surg Traumatol; 2019 Dec; 29(8):1729-1735. PubMed ID: 31359178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration.
    Wang D; Wang HY; Cao C; Li LL; Meng WK; Pei FX; Li DH; Zhou ZK; Zeng WN
    Sci Rep; 2018 Sep; 8(1):13579. PubMed ID: 30206267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial.
    Hill J; Magill P; Dorman A; Hogg R; Eggleton A; Benson G; McFarland M; Murphy L; Gardner E; Bryce L; Martin U; Adams C; Bell J; Campbell C; Agus A; Phair G; Molloy D; Mockford B; O'Hagan S; Beverland D
    Trials; 2018 Jul; 19(1):413. PubMed ID: 30064517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of oral vs. combined topical/intravenous/oral tranexamic acid in the prevention of blood loss in total knee arthroplasty: A randomised clinical trial.
    King L; Randle R; Dare W; Bernaitis N
    Orthop Traumatol Surg Res; 2019 Oct; 105(6):1073-1077. PubMed ID: 31473130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
    Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
    Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].
    Lošťák J; Gallo J; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2016; 83(4):254-262. PubMed ID: 28026726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty.
    Wu C; Tan C; Wang L
    Arch Orthop Trauma Surg; 2020 Dec; 140(12):2071-2075. PubMed ID: 32862267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Boluses of Intravenous Tranexamic Acid to Reduce Hidden Blood Loss After Primary Total Knee Arthroplasty Without Tourniquet: A Randomized Clinical Trial.
    Xie J; Ma J; Yao H; Yue C; Pei F
    J Arthroplasty; 2016 Nov; 31(11):2458-2464. PubMed ID: 27262419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.
    Wilde JM; Copp SN; McCauley JC; Bugbee WD
    J Bone Joint Surg Am; 2018 Jul; 100(13):1104-1109. PubMed ID: 29975264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty.
    Cankaya D; Dasar U; Satilmis AB; Basaran SH; Akkaya M; Bozkurt M
    J Orthop Surg (Hong Kong); 2017 Jan; 25(1):2309499016684725. PubMed ID: 28176599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Difference in Blood Loss and Risk of Transfusion Between Patients Treated with One or Two Doses of Intravenous Tranexamic Acid After Simultaneous Bilateral TKA.
    Wilde JM; Copp SN; Ezzet KA; Rosen AS; Walker RH; McCauley JC; Evans AS; Bugbee WD
    Clin Orthop Relat Res; 2022 Apr; 480(4):702-711. PubMed ID: 35302971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intra-articular versus intravenous tranexamic acid in reducing perioperative blood loss in total knee arthroplasty: a prospective randomized double-blind equivalence trial.
    Subramanyam KN; Khanchandani P; Tulajaprasad PV; Jaipuria J; Mundargi AV
    Bone Joint J; 2018 Feb; 100-B(2):152-160. PubMed ID: 29437056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.
    Xiong H; Liu Y; Zeng Y; Wu Y; Shen B
    BMC Musculoskelet Disord; 2018 Sep; 19(1):321. PubMed ID: 30193586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24).
    Magill P; Hill JC; Bryce L; Martin U; Dorman A; Hogg R; Campbell C; Gardner E; McFarland M; Bell J; Benson G; Beverland D
    Bone Joint J; 2021 Oct; 103-B(10):1595-1603. PubMed ID: 34587808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Nielsen CS; Jans Ø; Ørsnes T; Foss NB; Troelsen A; Husted H
    J Bone Joint Surg Am; 2016 May; 98(10):835-41. PubMed ID: 27194493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.